Bausch & Lomb, which is a leading supplier of contact lenses and lens care products, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The $100 million is a placeholder value and the actual deal proceeds should exceed $1 billion.
The Rochester, NY-based company, which was founded in 1853 and booked $3.0 billion in sales for the 12 months ended 12/31/2012, has not yet announced a ticker or exchange. Warburg Pincus (87% pre-IPO stake) acquired Bausch & Lomb for $3.7 billion in 2007. J.P. Morgan, BofA Merrill Lynch, and Citi are the joint bookrunners on the deal. No pricing terms were disclosed.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
